The United Kingdom Prospective Diabetes Study demonstrated the progressive decline in β-cell function that occurs over time in type 2 diabetes and the eventual need for insulin therapy in most patients [9,10]. This evidence concerns the gene INS and type 2 diabetes mellitus.